3ZE-17194-07132
4 vaccinations
0 coded responses
23 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 198 / DE
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
VRD-13330-70615
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-03-28
Registered in v-safe
-
2021-03-28
Dose 1 — Pfizer-BioNTech
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to workAdult check-in
- 2021-03-29
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-06
- 2021-04-11
-
2021-04-18
Dose 2 — Pfizer-BioNTech
- 2021-04-18
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-24
- 2021-04-25
- 2021-05-02
- 2021-05-16
- 2021-05-23
- 2021-05-31
- 2021-07-20
- 2021-10-17
-
2021-10-25
Dose 3 — Pfizer-BioNTech
- 2022-04-20
-
2022-05-16
Dose 4 — Pfizer-BioNTech
- 2022-06-23
- 2022-06-28
- 2022-08-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Pfizer-BioNTech | |
| 2 | 2021-04-18 | Pfizer-BioNTech | |
| 3 | 2021-10-25 | Pfizer-BioNTech | No |
| 4 | 2022-05-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-29 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.